Weekly Webinar

Join us for our Weekly Webinars every Thursday at 9:00 AM Eastern Time. For a list of topics and registration information go to the link below

Read More

Recent Events & Accomplishments

Read about our collective educational and research events as well as some landmark accomplishments.

Accomplishments

Become A Member

Learn about the advantages of membership today to reap the benefits of our education, research, collaboration, and communication. Help promote the innovation in Cardio Oncology. Bringing together cardiologists, oncologists, and primary care providers to deliver a multi-disciplinary and enhanced level of patient care.

Join Us
Welcome To

ICOS International Cardio-Oncology

Cancer and cardiovascular disease (CVD) are the two most common causes of death and disease worldwide! The incidence of both cancer and cardiovascular disease increases with age. With increased life expectancy, the burden of both diseases will increase substantially over the next decade. Also, advancement in cancer therapy and supportive care has led to an increasing number of survivors of childhood cancer. childhood cancer Seventy percent of the children diagnosed with malignancy before the age of 15 years will have a disease-free 5-year survival from diagnosis. Cancer is now being recognized as a chronic disease, as evidenced by a growing number of cancer survivors that currently exceeds 11 million. With further improvement in cancer therapy, this number will likely increase in years to come.

If you are interested in establishing a national chapter (with a minimum of team members) click here to contact our Executive Director.

What is Cardio-Oncology?

If you would like to have a copy of this animation for your own use, or a version in another language.

click here

left shape

IC-OS Board Review Book

“This is an outstanding reference resource for anyone interested in expanding their cardio-oncology knowledge.” Dr. Pedro Moliner, Pedro Moliner MD, PhD. Bellvitge University Hospital - Catalan Institute of Oncology. Barcelona, Spain.
  • cover
  • Daniel J. Lenihan, MD Jose A. Alvarez-Cardona, MD Ragavendra R. Baliga, MD, MBA, FIC-OS
bottom shape
Book-image

IC-OS Board Review Book now available

Price: $120

Available in Paperback

Please note that the materials purchased here are protected by copyright law and are not to be reproduced or
shared in any form without permission.

Buy Now

Price : $95

Now Available in Electronic Copy

You will receive an “EPub ” file so you have to open it with an e-reader such as IBooks or Calibre.

For more information:   Click Here

Buy Now
icis_book

Table of Contents:

  1. Basic Pharmacology
  2. Surveillance and Survivorship
  3. Treatment-Related Cardiotoxicity
  4. Electrophysiology and Cardio-Oncology
  5. Radiation-Induced Heart Disease
  6. Anticoagulation: Thromboprophylaxis and Treatment
  7. Rare Conditions and Syndromes
  8. Amyloidosis
  9. Miscellaneous
  10. Clinical Case Challenges
  11. Common Chemotherapy Regimen Acronyms

Weekly Webinars Now Available

  • First Thursday of the month : Journal Club
  • Second Thursday of the month : Case Reviews
  • Third Thursday of the month : Covid-19 Cardio-Oncology Issues
  • Fourth Thursday of the month : Topics in Cardio-Oncology
Join Here
BMC

Cardio-Oncology is now the official journal of ICOS

This partnership will expand and advance the understanding of cardiac complications of cancer treatments by providing ICOS members a platform for publication of original, peer-reviewed articles in the emerging field of study and research in cardio-oncology.

Learn More

Taking Survival To Heart

Vision

Eliminate cardiac disease as a barrier to effective cancer therapy in all of our patients being treated or who were previously treated for cancer.

Mission

ICOS exists to advance cardiovascular care of cancer patients and survivors by promoting collaboration among researchers, educators and clinicians around the world.

NO ONE HAS EVER BECOME POOR BY GIVING

Why does there need to be a focus on CardioOncology?

The complexity of contemporary cancer treatment has risen dramatically and patients are surviving even longer than ever before. As a result, cardiac disease comes to the forefront of long term survivorship.

Why donate time, energy, and money to the cause?

True multidisciplinary approaches to medical care are always valued and have dramatic improvements in overall outcomes.

Donate Now

Personalised management of Prostate Cancer patients with history and risk of CVD events

Module 2: Debate – How to manage CVD risk in PCa patients during COVID 19

Live webinar

    • Wednesday, 7 April 2021, 18:30 – 19:30 CET

Faculty

Moderator: Prof. P-A. Abrahamsson (SE)
Presenter: Prof. A. Ghosh (GB) – “Impact of COVID-19 on cardio-oncology”
Dr. M. Linch (GB) – “Hormonal treatment of urological cancers during COVID-19”
Dr. R.A. Rendon (CA) – “How to manage prostate cancer in a pandemic”
Prof. Dr. M.J. Ribal Caparros (ES) – “COVID-19 Recommendations for Prostate Cancer treatment by the EAU Guidelines”

Learn More
playlist By Cardio Oncology Society

All Things Cardio Oncology

Here is a resource for expanding your understanding of the growing field of cardio oncology in all its dimensions

Listen Here

Wherever you get your podcasts

  • apple_podcasts
  • spotify
  • radiopublic
  • pocket_casts
  • overcast
  • google_podcasts
  • breaker
img
right-image
“I shall ask God mercifully to protect us. Then I shall fumigate, help purify the air, administer medicine, and take it. I shall avoid places and persons where my presence is not needed in order not to become contaminated and thus perchance infect and pollute others, and so cause their death as a result of my negligence.” Martin Luther, 1527

Become a Volunteer and Do Something for Society

Thanks To Our Partners

large-astrazeneca-logo
bristol-myers-squibb-pfizer
Ferring-Blue-Logo-RGB-Low-Resolution-JPG